In 2015, Latham’s lawyers were everywhere. In Milan, Paris and Menlo Park, they helped an Italian client merge with a U.S. company, while simultaneously getting its stock listed in Europe. In Los Angeles, Chicago and London, they helped Allergan plc sell its generics business to Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. for $40.5 billion. And in New York, Washington, D.C., Brussels and the Bay Area, they helped install a holding company between Singapore-based Avago Technologies Ltd. and U.S.-based Broadcom Corp. to allow for a $37 billion tax-deferred deal between the two semiconductor companies.
“You need to have people that are on point, 24/7, around the globe,” said Latham partner Luke Bergstrom, who helped Italian client Sorin SpA in its merger with U.S.-based Cyberonics Inc. worth $2.7 billion. He was aided by lawyers in London, Chicago and New York, too. “The client can pick up the phone, call any of us, and know they’d get somebody who’d get them an answer.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
